Dr. Martine Dehlinger-Kremer is Vice President, Pediatric Development at Synteract, an innovative contract research organization. Dr. Martine Dehlinger-Kremer has 30 years of experience in the clinical research industry including 28 years in Regulatory and Medical Affairs. She has also been involved in Pediatrics in the last 10 years. Dr. Martine Dehlinger-Kremer has contributed to global development of numerous products, including orphan drugs and biosimilars. She has participated in 100+ New Drug Applications and Marketing Authorization Applications globally and in clinical studies across all phases. She is Chair of the Pediatric Working Group of EUCROF since 2008, Chair of the European Forum for GCP (EFGCP) Children Medicines Working Party, an Observer Member of the Coordinating Group of Enpr-EMA, the European Network of Pediatric Research at the European Medicines Agency (EMA) and since many years a member of Working Parties of Enpr-EMA. Dr. Martine Dehlinger-Kremer is President of EUCROF, the European CRO Federation, and a Board Member of EFGCP. Dr Dehlinger-Kremer was Named One of PharmaVOICE 100’s Most Inspiring People in Life Sciences (Industry leader recognized for impact, experience and advocacy in clinical research) in August 2015.
Dr. Dehlinger-Kremer holds a Doctorate in Sciences, a Master of Advanced Study in Neurophysiology degree, and a Master of Science degree.